🎉 M&A multiples are live!
Check it out!
Company | Headquarters | Sector | Stock Price | Enterprise Value | EV/Revenue | EV/EBITDA |
---|---|---|---|---|---|---|
Altria Group | United States of America | Tobacco | $57 | $117B | 5.8x | 9.4x |
Constellation Brands | United States of America | Alcohol | $186 | $45.0B | 4.4x | 11.6x |
Chart Industries | United States of America | Energy Equipment, Energy Storage, Machinery | $125 | $9.0B | 2.1x | 8.5x |
ScottsMiracle-Gro | United States of America | Agriculture | $51 | $5.6B | 1.6x | 10.3x |
Green Thumb Indus | Canada | Cannabis | CAD 7 | $1.5B | 1.3x | 4.1x |
Curaleaf | Canada | Cannabis | CAD 1 | $1.3B | 1.0x | 4.4x |
Cannae Holdings | United States of America | Restaurants & Nightlife | $17 | $1.3B | 2.8x | -15.1x |
Trulieve | Canada | Cannabis | CAD 5 | $1.1B | 1.0x | 2.8x |
Cresco Labs | Canada | Cannabis | CAD 1 | $705M | 1.0x | 3.7x |
Verano | Canada | Cannabis | CAD 1 | $611M | 0.7x | 2.3x |
Ayr Wellness | Canada | Cannabis | CAD 0 | $594M | 1.3x | 6.1x |
Tilray Brands | United States of America | Cannabis | $0 | $581M | 0.7x | 10.0x |
Ascend Wellness Holdings | Canada | Cannabis | $0 | $552M | N/A | N/A |
The Cannabist Company | Canada | Cannabis | CAD 0 | $452M | 1.0x | 9.1x |
Botanix Pharmaceuticals | Australia | Drug Development & Therapeutics, Biopharmaceuticals | AUD 0 | $379M | 43.2x | -14.9x |
Glass House Brands | Canada | Cannabis | $4 | $371M | N/A | N/A |
Canopy Growth | Canada | Cannabis, Health & Beauty | CAD 1 | $360M | 1.8x | -23.7x |
Jushi Holdings | Canada | Cannabis | CAD 0 | $303M | 1.2x | 6.4x |
TerrAscend | Canada | Cannabis | CAD 0 | $292M | 1.0x | 4.8x |
SNDL | United States of America | Alcohol, Cannabis | $1 | $281M | 0.4x | 66.7x |
iAnthus Capital | Canada | Cannabis, Drug Development & Therapeutics | CAD 0 | $237M | N/A | N/A |
Aurora Cannabis | Canada | Cannabis | CAD 6 | $222M | 0.9x | 5.8x |
High Tide | Canada | Cannabis, Pharmacies | CAD 3 | $181M | 0.5x | 7.6x |
Ispire Technology | United States of America | Tobacco, Cannabis | $3 | $161M | 1.0x | -42.1x |
Vireo Growth | Canada | Cannabis | CAD 1 | $135M | 1.3x | 5.3x |
MariMed | United States of America | Cannabis, Drug Development & Therapeutics | $0 | $111M | 0.7x | 5.2x |
Planet 13 Holdings | Canada | Cannabis | CAD 0 | $110M | 0.9x | 22.8x |
Intercure | United States of America | Drug Development & Therapeutics | $1 | $92.4M | N/A | N/A |
WM Tech | United States of America | Cannabis, Vertical Marketplaces, Consumer Marketplaces, Food Delivery | $1 | $86.8M | 0.5x | 2.2x |
Grown Rogue | Canada | Cannabis | CAD 1 | $83.5M | N/A | N/A |
Forian | United States of America | Healthcare Software | $2 | $33.3M | N/A | N/A |
CFN Enterprises | United States of America | Advertising & Marketing | $0 | $25.6M | N/A | N/A |
Anebulo Pharmaceuticals | United States of America | Drug Development & Therapeutics | $1 | $25.1M | N/A | N/A |
SynBiotic | Germany | Nutraceuticals & Cosmeceuticals, Health & Beauty | €3 | $19.5M | 0.9x | -37.1x |
Incannex | United States of America | Drug Development & Therapeutics | $1 | $19.3M | 80.8x | -0.8x |
Lexaria Bioscience | United States of America | Drug Delivery Systems | $1 | $15.7M | 33.7x | N/A |
Bakhu Holdings | United States of America | Cannabis | $0 | $12.7M | N/A | N/A |
Celadon Pharma | United Kingdom of Great Britain and Northern Ireland | Drug Development & Therapeutics, Cannabis | £0 | $11.9M | N/A | N/A |
Mira Pharmaceuticals | United States of America | Drug Development & Therapeutics | $1 | $10.8M | N/A | N/A |
Skye Bioscience | United States of America | Drug Development & Therapeutics | $1 | -$24.3M | N/A | N/A |
Cronos Group | Canada | Cannabis | CAD 2 | -$195M | -1.6x | 7.4x |
Valuation multiples as of last 12 months (LTM). Stock prices as of April 14, 2025. Financial data powered by Morningstar and FactSet.
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.